/H
ϩ exchanger (NHE) during ischemia is protective due to reduction of cytosolic Ca 2ϩ accumulation or enhanced acidosis in cardiomyocytes. Additionally, the role of the Na ϩ -HCO 3 Ϫ symporter (NBS) was investigated. Adult rat cardiomyocytes were exposed to simulated ischemia and reoxygenation. Cytosolic pH [2Ј,7Ј-bis(2-carboxyethyl)-5(6)-carboxyfluorescein (BCECF)], Ca 2ϩ (fura 2), Na ϩ [sodium-binding benzolfuran isophthatlate (SBFI)], and cell length were measured. NHE was inhibited with 3 mol/l HOE 642 or 1 mol/l 5-(N-ethyl-N-isopropyl)-amiloride (EIPA), and NBS was inhibited with HEPES buffer. During anoxia in bicarbonate buffer, cells developed acidosis and intracellular Na and Ca (Na i and Ca i , respectively) overload. During reoxygenation cells underwent hypercontracture (44.0 Ϯ 4.1% of the preanoxic length). During anoxia in bicarbonate buffer, inhibition of NHE had no effect on changes in intracellular pH (pH i ), Na i , and Ca i , but it significantly reduced the reoxygenation-induced hypercontracture (HOE: 61.0 Ϯ 1.4%, EIPA: 68.2 Ϯ 1.8%). The sole inhibition of NBS during anoxia was not protective. We conclude that inhibition of NHE during anoxia protects cardiomyocytes against reoxygenation injury independently of cytosolic acidification and Ca i overload.
hypercontracture; pH control; calcium; sodium-hydrogen exchanger IT HAS BEEN SHOWN that the ischemic-reperfused myocardium can be protected when the Na ϩ /H ϩ exchanger (NHE) is inhibited (27, 31) . Pronounced protection is achieved, however, only if the inhibitor of NHE is applied before or with the onset of ischemia (7, 15, 17, 25) . The mechanism of this protection is still unknown, but the following hypotheses have been put forward. First, inhibition of NHE reduces cytosolic Na ϩ accumulation (2) and subsequent Ca 2ϩ overload, which may result from reduced activity of the Na ϩ /Ca 2ϩ exchanger (NCE) in forward mode operation or from inhibition of its reverse mode operation (37) . Second, inhibition of NHE enhances acidification of the ischemic myocardial cell. Finally, reduced Ca 2ϩ overload and enhanced acidification is protective for the myocardial cell in ischemia-reperfusion (20, 21, 34) . The present study was undertaken to test these hypotheses at the cellular level. Additionally, we investigated whether the protective effect of NHE inhibition can be reproduced or enhanced by inhibition of another Na ϩ -dependent H ϩ extrusion system: the Na ϩ /HCO 3 Ϫ symporter (NBS). The role of NBS in the pathophysiology of ischemic myocardium (22) is still poorly understood, and it is unknown if sole inhibition of NBS can be as protective as sole inhibition of NHE.
As an experimental model we used isolated ventricular cardiomyocytes from the adult rat heart, which were exposed to a sequence of anoxia at extracellular pH (pH o ) 6.4 (simulated ischemia) and reoxygenation at pH o 7.4 (simulated reperfusion). This model has been characterized in previous studies (33, 35) . It was investigated, first, if the presence during simulated ischemic conditions of one of the chemically distinct NHE inhibitors HOE 642 (32) or 5-(N-ethyl-N-isopropyl)-amiloride (EIPA) alters the development of intracellular acidosis, Na ϩ , or Ca 2ϩ overload. Second, the results were compared for circumstances permitting bicarbonate-dependent sarcolemmal H ϩ transport and for circumstances that do not, i.e., the role of NBS was analyzed. Third, effects of intraischemic NHE inhibition on ischemic cells were differentiated from its effects on reoxygenated cells, specifically on reoxygenation-induced hypercontracture. The last point of this analysis is based on previous investigations on this model, which demonstrated that reoxygenation-induced hypercontracture is elicited by the coincidence of Ca 2ϩ overload, accumulated during ischemic conditions, and recovery of energy production within the reoxygenated cardiomyocyte (34) .
MATERIALS AND METHODS
Isolation of cardiomyocytes. Ventricular heart muscle cells were isolated from 200-to 250-g adult male Wistar rats and plated in medium 199 with 4% fetal calf serum on glass coverslips that had been preincubated overnight with 4% fetal calf serum (28, 29) . Four hours after plating the coverslips, the coverslips were washed with medium 199. As a result of the wash, damaged cells were removed, leaving a homogeneous population of rod-shaped quiescent cardiomyocytes (Ͼ95%) attached to the coverslip. From each isolation, two to three coverslips were used. On each coverslip, four to six cells were investigated. Only cells exhibiting a rod-shaped morphology and no signs of sarcolemmal blebbing were used for the experiments. , or H ϩ concentrations, cardiomyocytes were loaded in medium 199 at 35°C for 30 min with acetoxymethyl esters of fura 2 (2.5 mol/l), Mg-fura 2 (1.5 mol/l), sodium-binding benzolfuran isophthatlate (SBFI, 10 mol/l), or 2Ј,7Ј-bis(2-carboxyethyl)-5(6)-carboxyfluorescein (BCECF, 1.5 mol/l). After loading, cells were washed twice with medium 199 followed by incubation in medium 199 for 30 min to allow hydrolysis of the acetoxymethyl esters within the cell. The fluorescence from dye-loaded cells was 20-30 times higher than background fluorescence from unloaded cells.
The coverslip with loaded cells was introduced into a gas-tight, temperature-controlled (37°C), transparent perfusion chamber positioned in the light path of an inverted microscope (Diaphot TMD, Nikon, Dü sseldorf, Germany). Alternating excitation of the fluorescent dye at wavelengths of 340 and 380 nm for fura 2 and SBFI, 337 and 375 nm for Mg-fura 2, or 440 and 490 nm for BCECF was performed with an AR-Cation Measurement System adapted to the microscope (Spex Industries, Grasbrunn, Germany). Emitted light (490-510 nm for fura 2, SBFI; e.g., Mg-fura 2 and 520-560 nm for BCECF) from a 10 ϫ 10-mm area within a single fluorescent cell was collected by the photomultiplier of the Spex system. The light signal was recorded and analyzed by an IBM PC/AT-based data analysis system (model DM3000CM, Spex Industries). Simultaneously to the measurement of the fluorescence, the microscopic image of the cell was recorded with a video camera and stored on tape. From these recordings, changes of cell length were determined. In the case of a hypercontracted cell, the dimension of the cell along its previous longitudinal axis was determined.
The loading protocols used were selected from a number of variations because they provided the highest yield in fluorescence and minimal dye compartmentation. To assess the extent of intracellular dye compartmentation, cells were chemically "skinned" with digitonin as described previously (4) . This test showed that the fluorescent signal from intracellular stores did not exceed 10% for fura 2, 15% for SBFI, 15% for Mg-fura 2, and 12% for BCECF compared with the signal from whole cells. Furthermore, the extent of dye compartmentation did not differ significantly between control cells and cells after anoxia and reoxygenation. For the purpose of the present study, therefore, correction of the data for this small extent of dye compartmentation seemed unnecessary.
Because of the saturation limit of fura 2, Ca 2ϩ data were usually expressed in arbitrary units of fluorescence ratios of the emitted light of the two corresponding excitation wavelengths. To facilitate understanding, calibration protocols were performed to obtain numerical relationships between selected ratio values and ion concentrations. The fura 2 signal was calibrated according to the method described by Li et al. (23) . For this purpose, the cells were exposed to 5 mol/l ionomycin in modified Tyrode solution (pH 7.4; for composition see Media) containing either 3 mmol/l Ca 2ϩ or 5 mmol/l EGTA to obtain the maximum (R max ) and the minimum (R min ) ratio of fluorescence, respectively. To prevent morphological alterations during calibration, cells were depleted of ATP with 1 mmol/l KCN. The [Ca 2ϩ ] i was calculated according to Grynkiewicz et al. (13) with the use of pH-dependent dissociation constant (K d ) values for fura 2, determined in intact cardiomyocytes by constructing calibration curves. Calibrations under protocols 1-3 were performed separately for intracellular pH (pH i ) of normoxic control cells and for the end-anoxic pH i of anoxic cells. Calibrations for pH i Յ 6, as occurred at the end of anoxia under protocol 4, are not possible because the fura 2 signal loses Ca 2ϩ sensitivity at such low pH values. Calibration of the BCECF ratio signal was performed as previously described (19) , with 10 g/ml nigericin, a K ϩ -H ϩ ionophore, and incubation media with various pH values. SBFI ratio was calibrated according to Harootunian et al. (14) , with 6 mol/l gramicidin D and incubation in media containing various Na ϩ concentrations and pH values.
Media. The perfusion chamber (1 ml filling volume) placed on the microscope stage was perfused at a flow rate of 0.5 ml/min with modified, glucose-free normoxic bicarbonatebuffered solution at 37°C containing (in mmol/l) 118 NaCl, 2.6 KCl, 1.2 KH 2 PO 4 , 1.2 MgSO 4 , 1.0 CaCl 2 , and 22.0 NaHCO 3 ; the medium was gassed with 5% CO 2 -95% O 2 , and the resulting pH was 7.4. In the anoxic medium the bicarbonate concentration was reduced to 2.2 mmol/l, resulting in a pH of 6.4 when medium was gassed with 5% CO 2 -95% N 2 . NaCl concentration of the anoxic medium was elevated to 137.8 mmol/l to equalize Na ϩ concentrations of anoxic and normoxic media. Medium was made anoxic by autoclaving as described previously (1). To exclude the function of the HCO 3 Ϫ -dependent, pH-regulating mechanism, a bicarbonatefree, HEPES-buffered medium was used. The HEPES-buffered solution contained (in mmol/l) 140 NaCl, 2.6 KCl, 1.2 KH 2 PO 4 , 1.2 MgSO 4 , 1.0 CaCl 2 , and 25 HEPES; pH was adjusted at 7.4. For anoxic incubations, pH was adjusted at 6.4, and media were equilibrated with 100% N 2 . The pH of normoxic medium was adjusted to 7.4 and equilibrated with air. For the ammonium-prepulse experiments, we added 10 mM NH 4 Cl to the normoxic HEPES-buffered solution.
Simulated ischemia-reoxygenation. Four sets of experiments were used. In all of them, the anoxic period was 80 min at pH o 6.4 and 10 min reoxygenation at pH o 7.4 at 37°C. Under control conditions (protocol 1), cardiomyocytes were perfused with bicarbonate-buffered medium during simulated ischemia and reoxygenation. Under protocol 2, NHE was inhibited only during anoxia with 3 mol/l HOE 642, which was washed out with the onset of reoxygenation. Under protocols 3 and 4, cells were superfused with HEPESbuffered medium, to exclude the NBS. Under protocol 4, NHE was additionally inhibited only during anoxia with 3 mol/l HOE 642. To test the decline of the pH i in cardiomyocytes under normoxic conditions, we changed medium pH from 7.4 to 6.4 and perfused the normoxic cells for about 80 min with medium pH 6.4.
To exclude the protective side effects of HOE 642 independently from NHE inhibition, additional experiments following protocol 2 were performed with EIPA (1 mol/l).
Materials. Medium 199 was purchased from Boehringer Mannheim, fetal calf serum was from GIBCO, acetoxymethyl esters of fura 2 and BCECF were from Paesel and Lorey, EIPA was from RBI, and HOE 642 was a gift from Dr. H. J. Lang from Hoechst AG. All other chemicals were from Merck or Sigma and of the highest purity available.
Statistics. Data are given as mean values Ϯ SE from n individual cells investigated in separate experiments. Statistical comparisons were performed by one-way ANOVA and the Student-Newman-Keuls test for post hoc analysis. When only two experimental groups had to be compared, Student's t-test was applied. Differences with P Ͻ 0.05 were regarded as statistically significant.
RESULTS
Effect of HOE 642 and EIPA on pH i recovery after an ammonium prepulse. It was first tested whether 3 mol/l HOE 642, described as a blocking dose of the NHE inhibitor (30) , had indeed such an effect on the cardiomyocytes. An ammonium-prepulse test in normoxic HEPES buffer was used. Cardiomyocytes were superfused for 5 min with 10 mM NH 4 ϩ in HEPES buffer (pH 7.4) with following washout of NH 4 ϩ for another 15 min (Table 1) . This creates cytosolic acidification from which the cells spontaneously recover. Treatment of the cells with 3 mol/l HOE 642 only during the washout period completely abolished recovery from acidosis, indicating that this dosage blocks the NHE. These experiments were repeated with 1 mol/l EIPA. The data show ( Table 1 ) that 1 mol/l EIPA is also sufficient to abolish completely the pH i recovery after the ammonium prepulse. Therefore, HOE 642 and EIPA were administrated during anoxia at these tested concentrations.
Effect of HOE 642 on pH i during simulated ischemia and reperfusion in HEPES and bicarbonate-buffered medium. Under normoxic conditions at pH o of 7.4, the pH i of cells submitted subsequently to protocol 1 was 7.09 Ϯ 0.03 (n ϭ 22), for protocol 2 it was 7.11 Ϯ 0.04 (n ϭ 28), for protocol 3 it was 7.16 Ϯ 0.02 (n ϭ 25), and for protocol 4 it was 7.15 Ϯ 0.03 (n ϭ 25). When the cells were exposed to 80 min of anoxia in medium with pH 6.4 in bicarbonate-buffered medium (protocol 1), pH i declined to 6.46 Ϯ 0.04 (n ϭ 22) (Fig. 1) . Addition of 3 mol/l HOE 642 to the anoxic bicarbonate-buffered medium (protocol 2) had no significant effect on the development of intracellular acidosis. After 80 min of anoxia, pH i in these cells was 6.38 Ϯ 0.04 (n ϭ 28; not significant vs. protocol 1). When anoxia was performed in HEPES-buffered medium (protocol 3), pH i declined to 6.45 Ϯ 0.03; (n ϭ 25; not significant vs. protocol 1). When HOE 642 was present in anoxic, HEPES-buffered medium (protocol 4), the cytosolic acidification was markedly enhanced. After 80 min of anoxia, pH i was 5.44 Ϯ 0.07 (n ϭ 25; P Ͻ 0.05 vs. protocols [1] [2] [3] . Superfusion with bicarbonate-buffered normoxic medium at pH 6.4 produced intracellular acidification of the cardiomyocytes but not as strongly as under anoxic conditions. During 80 min of normoxia at pH 6.4, the pH i of the cardiomyocytes decreased from 7.05 Ϯ 0.01 (n ϭ 20) to 6.79 Ϯ 0.02 (n ϭ 20).
During 10 min of reoxygenation in medium with pH 7.4, pH i returned from the end-anoxic value (6.46 Ϯ 0.04) to the preanoxic control value (7.02 Ϯ 0.04; n ϭ 22) under protocol 1. Similar recovery of pH i was observed under protocol 2. Under protocol 3, pH i recovered with a small delay (protocol 1: 6.88 Ϯ 0.05; n ϭ 22; protocol 3: 6.6 Ϯ 0.3; n ϭ 25; P Ͻ 0.05; after 5 min of reoxygenation). Under protocol 4, pH i at the end of anoxia was significantly lower than in other groups. Consequently, under this protocol, pH i at the fifth and tenth minute of reoxygenation was also distinctly lower than in the other groups (Fig. 1) . Thus simultaneous inhibition of both acid extrusion systems during anoxia caused a pronounced cytosolic acidosis. Inhibition of either NHE or NBS alone did not alter the anoxic decline of pH i .
Time of rigor contracture and cytosolic Mg 2ϩ concentration. After extensive loss of high-energy phosphates, cardiomyocytes develop rigor contracture (5), causing shortening of the cells by one-third of their resting length within 1 min. Under control conditions in the present study, cells developed rigor contracture after 36.5 Ϯ 5.9 min (n ϭ 38) of anoxia. Inhibition during anoxia of NHE or NBS or both did not influence the onset of rigor contracture ( Table 2) .
As another indirect indicator of cytosolic ATP depletion, we used the rise of cytosolic free Mg 2ϩ measured with the fluorescent indicator Mg-fura 2. It has been shown previously that the concentration of Mg 2ϩ in the cytosol rises during ischemia as a result of ATP degra- dation (6) . We found that the Mg-fura 2 signal started to rise during anoxia a few minutes before rigor contracture and reached its plateau just after rigor contracture ( Fig. 2A) . The same relationship between time of rigor contracture and rise of the Mg-fura 2 signal was observed under all other investigated anoxic conditions. As an example, data of a cell under protocol 2 are shown in Fig. 2B . overload. When cells were reoxygenated in medium with pH 7.4, the fura 2 ratio declined to the initial control value within 10 min (Fig. 3) . Under protocols 2 and 3, the cardiomyocytes showed no significant differences in the rate of ischemic Ca 2ϩ accumulation compared with protocol 1, as indicated by the rise of the fura 2 ratio. There were no differences either during reoxygenation in the recovery of cytosolic Ca 2ϩ control. When both NHE and NBS were inhibited under protocol 4, a significant reduction of fura 2 ratio increase was observed (Fig. 3) . The corresponding Ca 2ϩ concentrations could not be determined in this latter case, because the fura 2 ratio cannot be calibrated at the concomitant low pH i .
Changes in [Ca
Effect of inhibition of NHE on reoxygenation-induced hypercontracture. During anoxia, the cell length was reduced by about one-third of the initial length due to rigor shortening. This rigor shortening was similar under all experimental conditions; an average cell retained 70.0 Ϯ 1.3% of their initial length. Reoxygenation of cells after anoxia led to additional, irreversible reduction of cell length, i.e., hypercontracture (21) . In  Fig. 4 , the changes in cell length induced by reoxygenation are shown. When cells were reoxygenated under the conditions of protocol 1, they rapidly developed hypercontracture, resulting in 44.0 Ϯ 4.1% (n ϭ 42) of initial cell length. Inhibition of NHE during simulated ischemia under protocol 2 protected against the subsequent reoxygenation-induced hypercontracture. The length of these cells was only slightly reduced to 61.0 Ϯ 1.4% (n ϭ 35; P Ͻ 0.05 vs. protocol 1) of initial cell length. Inhibition of NBS during simulated ischemia under protocol 3 did not influence the degree of subsequent reoxygenation-induced hypercontracture. Under protocol 4, where NHE and the NBS were inhibited simultaneously, reoxygenation-induced hypercontracture was partly prevented in a degree similar to protocol 2. The data show that inhibition of NHE alone or simultaneous inhibition of NHE and NBS during simulated ischemia can protect adult cardiomyocytes against hypercontracture elicited by subsequent reoxygenation. Anoxic inhibition of NBS alone is not protective.
Effect of NHE inhibition on cytosolic Na ϩ loading. The aforementioned results showed that the sole inhibition of NHE during anoxia at pH o 6.4 (protocol 2) can effectively protect cardiomyocytes from hypercontracture otherwise occurring upon reoxygenation (protocol 1). We therefore extended our experimental analysis of protocol 2 versus protocol 1, with respect to possible effects of NHE inhibition on cytosolic Na ϩ loading. Changes in cytosolic Na ϩ during anoxia and reoxygenation were analyzed with SBFI. Under protocol 1, the SBFI ratio rose from an initial value of 0.6 Ϯ 0.01 (n ϭ 32) to a value of 0.77 Ϯ 0.02 (n ϭ 32) after 80 min of anoxia, corresponding to a rise of intracellular Na ϩ concentration from 15 to 84 mmol/l. Treatment of the cells with HOE 642 in bicarbonate containing buffer (protocol 2) did not significantly influence the rate of rise as well as the end-anoxic value of the SBFI ratio (0.76 Ϯ 0.02; n ϭ 28) (Fig. 5) . During reoxygenation, the SBFI ratio falls to its normoxic control level within 10 min under either protocol. These results agree with those on changes in [Ca 2ϩ ] i and pH i , reported above, which were also not different between protocols 1 and 2.
Effect of anoxic inhibition of NHE with EIPA on [Ca 2ϩ ] i , pH i, and reoxygenation-induced hypercontracture. In an additional set of experiments, the chemically distinct inhibitor EIPA was used instead of HOE 642. The data in Table 3 demonstrate that EIPA does not influence the anoxic calcium loading nor the acidification of the cytosol. Neither was the time of rigor contracture different from the anoxic control cells (data not shown). The cardiomyocytes exposed to EIPA during anoxia were nevertheless protected against reoxygenation-induced hypercontracture (Table 3) .
Because of the slower outwash of EIPA during the reoxygenation period, the pH i recovery during reoxygenation was slightly delayed compared with control conditions. We therefore tested whether the sole presence of EIPA during reoxygenation would affect hypercontracture development. With EIPA solely present during reoxygenation, pH i recovered at the same pace as when applied during anoxia and washed out during reoxygenation (after 5 min of reoxygenation: 6.77 Ϯ 0.03; n ϭ 30; vs. 6.80 Ϯ 0.02; n ϭ 31; after 10 min reoxygenation: 6.96 Ϯ 0.03 ; n ϭ 30; vs. 6.98 Ϯ 0.02; n ϭ 30). When EIPA was solely present during reoxygenation, it had no effect on hypercontracture. The cells shortened to 38.7 Ϯ 2.5% of initial length (n ϭ 30) compared with 68.2 Ϯ 1.8% (n ϭ 42) when EIPA was present solely during anoxia (P Ͻ 0.05).
DISCUSSION
The aim of the present study was to investigate whether inhibition of the NHE and/or the NBS during simulated ischemia can protect cardiomyocytes during simulated ischemia or upon reoxygenation. The main finding is that an inhibition of the NHE with HOE 642 or EIPA solely during ischemic conditions protects cardiomyocytes against reoxygenation-induced hypercontracture independently of ischemic Ca 2ϩ overload and cytosolic acidification. Additional inhibition of the NBS significantly enhances ischemic cytosolic acidosis but does not provide additional protection against reoxygenation-induced hypercontracture. The sole inhibi- tion of the NBS during ischemic conditions shows no protective effects.
The model of isolated cardiomyocytes exposed to anoxia in medium with pH 6.4 and subsequent reoxygenation in normoxic medium with pH 7.4 has been characterized in earlier studies (20, 21, 34) . Depleted from oxygen, the cells develop a deficit of energy that causes a rigor-mediated partial shortening of the myofibrils. H ϩ , Na ϩ , and Ca 2ϩ accumulate in the cytosol. This ionic imbalance is rapidly reversed when cells are reenergized during reoxygenation. When reoxygenation is performed on cells that have already developed severe Ca 2ϩ overload, they rapidly undergo hypercontracture. This results from the resupply of energy to the myofibrils at elevated [Ca 2ϩ ] i (20, 34) , predominantly occurring in the form of rapid Ca 2ϩ oscillations. Reoxygenation-induced hypercontracture has been demonstrated in studies in vitro (10, 16, 36) and in vivo (3) to contribute substantially to lethal reperfusion injury of myocardial cells and thus to the postischemic extent of myocardial infarction. In the isolated cell model, hypercontracture develops without disruption of the sarcolemma because the cells do not mutually exchange force.
When anoxia was performed in bicarbonate-buffered media (pH o ϭ 6.4), the pH i of the cardiomyocytes declined from 7.1 to 6.4 (protocol 1). In the presence of the NHE inhibitors HOE 642 or EIPA the development of intracellular acidosis was not significantly altered (protocol 2; see Table 2 ). This was the case even though these drugs at the chosen concentration are shown to completely inhibit NHE-dependent proton extrusion in this cell model. For protocols 1 and 2, the development of anoxic Na ϩ overload was also compared and not found different (see Fig. 5 and Table 2 ). In another set of experiments, bicarbonate buffer was replaced with HEPES buffer throughout simulated ischemia to abolish activity of the NBS (protocol 3). In HEPES buffer, the pH i decline during anoxia was not significantly altered. Only when the change of buffer was combined with the presence of HOE 642, i.e., when both NBS and NHE were blocked, intracellular acidosis was markedly enhanced, leading to pH i 5.5 at the end of anoxia (protocol 4). These results show that during anoxia, these two proton extruders can mutually compensate their actions in the investigated model. Under all protocols, pH i rapidly recovered when cells were reoxygenated in media with pH 7.4. The recovery of pH i was slightly delayed under protocol 3 and markedly under protocol 4 when the cardiomyocytes had to recover from an enhanced acidosis.
Within the investigated period of simulated ischemia, the cardiomyocytes underwent rigor shortening. This caused a reduction in cell length by approximately one-third. As shown before, rigor shortening is due to extensive loss of energy (5). It develops rapidly, i.e., in less than a minute, which allows one to define a "rigor time" (Table 2 ) during anoxia. Rigor times coincide with the points in time when the Mg-fura 2 signal starts to rise rapidly, indicative of a rapid rise in cytosolic free Mg 2ϩ . The concentration of Mg 2ϩ in the cytosol increases during ischemia as a result of ATP degradation (6) . Rigor times were not significantly different among the four investigated anoxic protocols. This indicates that anoxic energy depletion proceeds at similar pace under all protocols. Consequently, differences in energy depletion cannot be responsible for differences in the outcome of the different protocols.
It has been observed consistently that rigor time coincides with or precedes immediately the onset of cytosolic Ca 2ϩ accumulation (21, 35) . Onset or rate of cytosolic Ca 2ϩ accumulation during anoxia was not affected by either inhibition of NHE or NBS alone. The rise of the fura 2 ratio, used to follow Ca 2ϩ overload, was attenuated when both routes for H ϩ extrusion were blocked simultaneously (protocol 4), but this observation has to be interpreted with caution because of the pH dependence of the fura 2 ratio.
When cells were reoxygenated after prolonged ischemic conditions, they rapidly underwent hypercontracture. Hypercontracture is caused by an uncontrolled activation of the contractile machinery, which is elicited when the cells are reenergized in the presence of severe cytosolic Ca 2ϩ overload (20) . We showed previously (21) that reoxygenated cardiomyocytes can be protected against reoxygenation-induced hypercontracture through a preservation of ischemic cytosolic acidosis during the initial phase of reoxygenation. The results of protocols 1, 3, and 4 are consistent with these previous results because they show that 1) cardiomyocytes develop reoxygenation-induced hypercontracture when pH i recovers rapidly upon reoxygenation (protocols 1 and 3) and 2) hypercontracture is significantly reduced when pH i recovery is markedly delayed (protocol 4). The protection against hypercontracture of protocol 2, however, cannot be explained on these grounds. Under protocol 2, pH i recovered with similar rapidity as under protocol 1, but the observed protec- tion against hypercontracture was similar to protocol 4 where pH i recovery was delayed. Therefore, the ability of protocol 2 to protect against reoxygenation-induced hypercontracture cannot be attributed to a prolongation of cytosolic acidosis. Neither is its success explained by intraischemic differences in acidosis, Na ϩ or Ca 2ϩ overload, or energy depletion (see above). This indicates that the presence of NHE inhibitor HOE 642 exerts a protective effect, which is independent of these parameters. To corroborate this point and to exclude effects related to the particular chemical structure of HOE 642, the decisive experiment of protocol 2 was repeated with the chemically distinct NHE inhibitor EIPA. We found that EIPA acts in the same manner as HOE 642. Taken together, these results indicate that intraischemic inhibition of the NHE provides protection by a mechanism independent of the development of cytosolic acidification, Na ϩ overload, and subsequent Ca 2ϩ overload. Our results are in apparent opposition to the findings of others, who reported a reduction in Ca 2ϩ or Na ϩ overload when the NHE was inhibited in ischemic myocardium (2, 8, 15, 24, 26) . A possible explanation for this difference may be that most studies were performed with amiloride, which is known to exert inhibitory side effects also on the sarcolemmal Na ϩ /Ca 2ϩ exchanger (18) and L-type Ca 2ϩ channel (11) . In some of the studies, the NHE blockers were tested only in bicarbonate-free perfusates (21, 26) , i.e., conditions comparable to protocol 4. The findings of Choy et al. (8) , who observed a reduction in cytosolic Na ϩ loading, cannot be compared with our results because they tested the effect of HOE 642 in combination with a cardioplegic solution with high potassium, which causes depolarization of the membrane and multiple changes in ionic transport mechanisms. The results of Hendrikx et al. (15) show, by histochemical methods, a reduction of Ca 2ϩ precipitates in mitochondria in ischemic-reperfused myocardium pretreated with HOE 694, indicating reduction of cell injury. Cytosolic free Ca 2ϩ during ischemia was not determined. In general, it seems appropriate to say that none of these studies went beyond an observational association of protection with changes in cytosolic Na ϩ and Ca 2ϩ , i.e., the causal role of either parameter was not tested independently. In any case, our study shows that NHE inhibitors exert a protective effect on cardiomyocytes beyond effects possibly associated with the intraischemic changes in cytosolic cation control observed in other models.
In the investigated model, the results of our study contradict the favored hypothesis that the presence of NHE inhibitors throughout ischemia protects myocardial cells under ischemia-reperfusion conditions, because it changes the cytosolic H ϩ and Na ϩ balance and consequently the cytosolic Ca 2ϩ balance under the ischemic conditions. One may avoid that conclusion by assuming that these changes occur only in a small subsarcolemmal space and have therefore escaped our analysis, but it would be difficult to relate such small local ionic changes to the distinct protection against reoxygenation-induced hypercontracture demonstrated in the presence study. It is more plausible to hypothesize that the protective mechanism of the NHE inhibitors is due to an effect unrelated to NHE ion transport function. One may speculate that the NHE molecule is structurally or functionally linked to cytoskeletal elements (12, 38) involved in the process of hypercontracture development.
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